Zolpidem Impurity 13 | CAS 2514723-02-3 - Request Quote
Zolpidem Impurity 13
| SZ CAT No: | SZ-Z016028 |
| CAS No | 2514723-02-3 |
| Mol.F. | C15H13BrN2 |
| Mol.Wt. | 301.2 |
| Inv. Status | Synthesis on demand |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Zolpidem Impurity 13 is chemically 2-(3-Bromo-4-methylphenyl)-6-methylimidazo[1,2-a]pyridine. Zolpidem Impurity 13 is supplied with detailed characterization data compliant with regulatory guideline. Zolpidem Impurity 13 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Zolpidem.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2514723-02-3
Purchase 2514723-02-3
Order 2514723-02-3
Enquire 2514723-02-3
price of 2514723-02-3
2514723-02-3 Supplier
2514723-02-3 Manufacturer
2514723-02-3 Exporter
buy high quality Zolpidem Impurity 13
Purchase Zolpidem Impurity 13
Zolpidem Impurity 13 suppliers
Zolpidem Impurity 13 manufacturers
Zolpidem Impurity 13 price
Order Zolpidem Impurity 13
Enquire Zolpidem Impurity 13
Zolpidem Impurity 13 cost
Zolpidem Impurity 13 Supplier
Zolpidem Impurity 13 Distributor
Zolpidem Impurity 13 for Method Validation
Zolpidem Reference Standard
Zolpidem Impurity 13 for ANDA Filing
Zolpidem Impurity 13 for Forced Degradation Studies
Zolpidem Impurity 13 Identification Standards
Zolpidem Impurity 13 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


